Primary record
1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt; Cefepime Impurity A; Cefepime EP Impurity A
- 库存
- 1,837 克
- 纯度
- 98.1 %
- CAS
- 97164-57-3
化合物标识与属性
- CAS
- 97164-57-3
- PubChem CID
- 5464190
- SMILES
- C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
- Canonical SMILES
- CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1
名称与同义词
- cefepime
- Cefepime, E-
- E-Cefepime
- Anti-cefepime
- Anticefepime
- Cefepima
- Cefepimum
- Maxipime
- Cefepime EP Impurity A
- Cefepimum [Latin]
- Cefepima [Spanish]
- Cefepime Impurity A
- Cefepime related compound A
- Cefepime, BMY-2
- Cefepime impurity A [EP]
- Anticefepime (>90%)
- Cefepime [USAN:INN]
- AC1NUZ1E
- RefChem:1081315
- UNII-807PW4VQE3
- Cefepime [USAN:INN:BAN]
- Arginine mixture with cefepime
- BIDD:GT0809
- Cefepime mixture with arginine
- DTXSID60164213
- 97164-57-3
- UNII-Z0114Q3738
- Cefepime related compound A [USP]
- Cefepime specified impurity A [EP]
- DTXCID1086704
- SCHEMBL27794664
- C19H24N6O5S2
- HVFLCNVBZFFHBT-ZKDACBOMSA-N
- BMY 28142
- Cefepime Hydrochloride EP Impurity A
- Z0114Q3738
- 88040-23-7
- AKOS015895225
- BMY-28142 L-arginine dihydrochloride
- C19-H24-N6-O5-S2
- CID5464190
- 149261-27-8
- CEFEPIME IMPURITY A [EP IMPURITY]
- C6H14N4O2.C19H24N6O5S2.2ClH
- CEFEPIME IMPURITY A (REFERENCE GRADE)
- Cefepime dihydrochloride monohydrate impurity A [EP]
- CEFEPIME RELATED COMPOUND A [USP IMPURITY]
- (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Q27294816
- (6R,7R)-7-(((2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl)amino)-3-((1-methylpyrrolidinio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- C6-H14-N4-O2.C19-H24-N6-O5-S2.2Cl-H
- B1370-153673
- (6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 143892-90-4
- Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, (6R-(6alpha,7beta(E)))-
- CEFEPIME DIHYDROCHLORIDE MONOHYDRATE IMPURITY A [EP IMPURITY]
- (6R,7R)-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-METHOXYIMINO-ACETYL]AMINO]-3-[(1-METHYL-2,3,4,5-TETRAHYDROPYRROL-1-YL)METHYL]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
- (6R,7R)-7-{[(2E)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- -7-[[ -2- -2-methoxyimino-acetyl]amino]-3-[ methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- [6R-[6.alpha.,7.beta.(Z)]]-1-[[7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium, hydroxide, inner salt
- 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime)
- 1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt
- 1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt; Cefepime Impurity A; Cefepime EP Impurity A
- PYRROLIDINIUM, 1-((7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-1-METHYL-, (6R-(6.ALPHA.,7.BETA.(E)))-